Knowledge Center

Article / Feb 01, 2015

The Time Has Come

Authors:
  • Goncalo Andrade
  • Peter Villax
  • Carla Vozone
Source:
PMPS, 2015, February, pp. 30 - 33

The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.

With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.

Related links

Read article here

Also in the Knowledge Center

Related Content

Membrane Technology

Hovione has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page
Read more

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more